. Author manuscript; available in PMC: 2007 Oct 18.

Published in final edited form as: Pacing Clin Electrophysiol. 2002 Mar;25(3):332–341. doi: 10.1046/j.1460-9592.2002.00332.x

Table VIII.

Patient Demographics

	PAPCA	Registry
Mean age years	11.3 ± 3.7	13.1 ± 4.2
Mean weight kg	44.6 ± 17.9	52.2 ± 20.2
Sex % of male	52%	56%
Structural heart disease
Congenital	2%	11%
Cardiomyopathy	1%	2%
Indication for ablation
Life-threatening arrhythmia	7%	10%
Refractory to drug treatment	15%	16%
Adverse drug effects	1%	2%
Impending CHD surgery	0	2%
Patient choice	75%	68%
Cardiomyopathy	1%	2%
Fluoroscopy Time	39.9 ± 31.0	36.7 ± 34.2

PAPCA = Prospective Assessment After Pediatric Cardiac Ablation Study; CHD = congenital heart disease.